Philip Morris Stock Records 50% YTD Surge: Is it Too Late to Buy?

Philip Morris (PM) has surged 50.1% YTD, significantly outperforming its peers and the broader market, driven by strong growth in its smoke-free products, including IQOS and ZYN, with smoke-free net revenues up 20.4% in Q1 2025. The company's shift towards reduced-risk products and strong pricing power in traditional tobacco contribute to its positive outlook, as PM projects 2025 adjusted EPS of $7.36-$7.49, reflecting 12-14% growth. PM's forward P/E ratio of 23.04, higher than the industry average, signals investor confidence in its long-term growth trajectory and strategic transformation.

Analysis

Philip Morris International (PM) has demonstrated exceptional market outperformance year-to-date in 2025, with its stock surging 50.1%, substantially exceeding the Zacks Tobacco industry's 38.8% rise, the Zacks Consumer Staples sector's 7% growth, and the S&P 500's modest 0.9% increase. This rally, which has also outpaced competitors Altria (13.4% YTD), British American Tobacco (27.1% YTD), and Turning Point Brands (24.7% YTD), is underpinned by a successful strategy combining premium pricing in traditional tobacco, aggressive expansion in its smoke-free product portfolio, and stringent cost controls. The smoke-free segment is a key growth catalyst, evidenced by a 20.4% increase in smoke-free net revenues and a 33.1% rise in gross profit in Q1 2025, achieving a gross margin exceeding 70%, more than 500 basis points higher than combustibles. Specifically, IQOS saw 9.4% HTU-adjusted IMS growth, ZYN nicotine pouch shipments surged 53% to 202 million cans in Q1 leading to an upgraded 2025 shipment forecast of 800-840 million cans, and VEEV e-vapor volumes more than doubled. Concurrently, PM's combustible tobacco business remains resilient, with Q1 2025 organic net revenue growth of 3.8% and organic gross profit growth of 5.3%, alongside a 0.4 percentage point increase in total cigarette category share to 24.8%. The company's robust outlook for 2025 includes projected total volume growth of 2%, smoke-free volume growth of 12-14%, organic net revenue growth of 6-8%, and adjusted EPS guidance of $7.36-$7.49, implying 12-14% growth. This positive financial trajectory is supported by bullish Zacks Consensus Estimates, projecting 13.7% EPS growth for 2025 and 11.7% for 2026. Technically, the stock, closing at $180.66 on June 4, 2025, trades 1.8% below its 52-week high and above its 50-day and 200-day moving averages, while its forward P/E ratio of 23.04, though above the industry average of 15.49, reflects strong investor confidence in its transformation and future growth prospects.

Key Decisions for Investors

• Investors should recognize Philip Morris's significant momentum driven by its rapidly expanding and highly profitable smoke-free segment, which, coupled with a resilient combustible business and strong earnings guidance, underpins its premium valuation.
• Continued monitoring of ZYN's supply-demand balance and upgraded shipment capacity, IQOS's international market penetration, and overall smoke-free product margin trends is crucial for assessing the sustainability of the company's growth trajectory and profitability.
• While the stock trades near its peak and at a higher P/E ratio compared to peers, the company's successful strategic transformation towards reduced-risk products and robust financial outlook provide a strong rationale for its current market positioning, warranting careful consideration for inclusion in growth-oriented portfolios.